Application Deadline:
21 May 2026
About Organisation
The Pfizer Inc. is a global biopharmaceutical company known for advancing healthcare through innovation, research, and education. It develops medicines and vaccines across multiple therapeutic areas, including immunology and rheumatology. Through its Independent Medical Education (IME) grants, Pfizer supports unbiased, evidence-based learning initiatives for healthcare professionals. These programs aim to improve clinical knowledge, patient care, and health outcomes worldwide. By funding educational projects, Pfizer contributes to bridging knowledge gaps and ensuring that clinicians are equipped with the latest scientific evidence to make informed treatment decisions in evolving medical landscapes.
About the Grant
The Pfizer Independent Medical Education Grant supports educational projects focused on the clinical role and real-world impact of generic JAK inhibitors in rheumatologic diseases. It aims to enhance healthcare professionals’ understanding of emerging evidence and evolving treatment pathways. The grant funds initiatives that translate research findings into practical, evidence-based clinical decision-making. Projects may include CME programs, virtual learning, and case-based education. With a maximum duration of 12 months, the grant encourages targeted, high-impact educational interventions. This opportunity is particularly relevant as generic JAK inhibitors are expected to reshape treatment approaches in the United States healthcare system.
Who can Apply?
Eligible applicants include healthcare institutions, professional medical societies, medical education companies, and organizations involved in healthcare education or quality improvement. Applicants must be legally able to receive funding from Pfizer and play a central role in project implementation. The organization must demonstrate the capacity to design and deliver independent, evidence-based educational initiatives. Individual applicants and independent physician groups are not eligible. Projects should address clear educational gaps in rheumatology, particularly around JAK inhibitors, and include measurable outcomes. If offering continuing education credits, applicants must have appropriate accreditation to deliver CME or CE programs.
How to Apply?
Applicants should confirm organizational eligibility and identify a clear educational gap in rheumatology related to JAK inhibitors. Develop a focused, evidence-based educational proposal with measurable outcomes. Choose appropriate formats such as CME programs or virtual learning modules. Ensure independence and scientific accuracy in content. Prepare a realistic budget within $100,000 and verify accreditation requirements if offering continuing education credits. Submit the proposal before the deadline.
Application Deadline
The application deadline for the Pfizer JAK Inhibitors Rheumatology Grant is 21 May 2026, allowing organizations time to develop strong, evidence-based educational proposals
Last Date To Apply
For more information, please visit the grant website here.
